IRCT201505106252N7已完成未知
Comparison of the effect and side effects of Azitromycin and co- Amoxiclav in the treatment of acute bacterial sinusitis in adults.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 years 至 65 years（—）
- 性别
- All
入选标准
- •Existing at least two major criteria or one major criteria and two minor criteria that lasting at least 7 days and at most 28 days. Major criteria are: facial pain or pressure; facial fullness or congestion; nasal obstruction; purulent rhinorrhea or postnasal discharge; loss of smell; fever. Minor criteria: headache; halitosis; fatigue; toothache; cough; otalgia; fullness of ear.
- •Exclusion criteria: Patients with chronic sinusitis; patients with recurrent sinusitis; patients with anatomical disorders( severe septal deviation; cleft palate; nasal poliposis; patients with chronic disorders (severe hepatic disease; renal disease; heart disease and asthma); women in pregnancy and breast feeding; history of sensitivity to co_ amoxiclav or azitromycin; patients with cilliary dysfunction; cystic fibrosis; congenital or acquired immune deficiency (HIV; diabetes); complications of sinusitis; antibiotic consumption in last one month; patients less than 12 years old or more than 65 years old.
排除标准
- 未提供
研究者
相似试验
尚未招募
4 期
The effectiveness of azithromycin alone and azithromycin plus cefixime for the treatment of typhoid fever in South Asia has been studied.CTRI/2021/10/037047The University of Oxford
尚未招募
Unknown
A Observational Study to understand the Effectiveness and Tolerability of Azithromycin on Patients with Upper Respiratory Tract Infection.CTRI/2024/04/066497Alembic Pharmaceuticals Ltd.
招募中
3 期
Comparison of the Efficacy of the Azithromycin and in Combination with Moxifloxacin on Chlamydial CervicitisIRCT20100130003226N16Shahid Beheshti University of Medical Sciences120
招募中
3 期
ong-term treatment with azithromycin to prevent bronchiectasis and recurrent cough (LEAP-Cough)Chronic wet coughRespiratory - Other respiratory disorders / diseasesACTRN12623000098639Queensland University of Technology274
进行中（未招募）
不适用
Clinical and biological evaluation of azacitidine in transfusion-dependent patients with Low and intermediate-1 risk MDS, and low-risk CMML, who are either refractory to or not eligible for treatment with erythropoietin +/- G-CSFow and intermediate-1 risk MDS, and low-risk CMML.MedDRA version: 12.0Level: LLTClassification code 10009018Term: Chronic myelomonocytic leukaemiaMedDRA version: 12.0Level: LLTClassification code 10028533Term: Myelodysplastic syndromeEUCTR2009-011483-11-DKMDSG30